Signals

2.9K posts

Signals banner
Signals

Signals

@Signalsblogs

A Canadian-based blog featuring insiders' perspectives on the world of stem cells and regenerative medicine. Published by CCRM.

Toronto, Ontario Katılım Mayıs 2018
350 Takip Edilen575 Takipçiler
Signals retweetledi
ISCT
ISCT@ISCTglobal·
Every fellowship year belongs here, first-years included. Starting early is an advantage, not a disqualifier. This program teaches fellows to lead programs that deliver CGT applications. Interested in this program? Know a fellow who might? Apply by Jul 31: buff.ly/gLfkEvc
ISCT tweet media
English
0
1
1
117
Signals retweetledi
RegMedNet
RegMedNet@RegMedNet·
What's the latest in cell and gene therapy? Catch up here: hubs.ly/Q04pHJ3Y0 This week: >/ Apertura Gene Therapy announced that it has entered into a Cooperative Research and Development Agreement to evaluate the systemic delivery of an investigational gene therapy for Niemann-Pick Disease Type C1 >/ Scripps Research presented encouraging interim clinical data from its Phase I/IIa assessing a stem cell therapy for Parkinson’s disease at ISSCR >/ The FDA expanded the age range of Vertex Pharmaceutical’s Casgevy to include younger patients
RegMedNet tweet media
English
0
2
1
112
Signals retweetledi
Stacey Johnson
Stacey Johnson@msstaceyerin·
Along with a brand new season, we have @KristaLambComms returning as our host. I'm excited about season 5. Please tune it! #misinformation #disinformation
CCRM@CCRM_ca

How do we separate fact from fiction in CGTs? To kick off season 5 of #CCRMpodcast, @heysciencesam & Megan Munsie discuss the growing challenge of misinformation, the risks it poses to patients & innovation, & more. Listen where you stream podcasts or at ccrm.ca/podcast.

English
0
1
2
61
Signals retweetledi
CCRM
CCRM@CCRM_ca·
The 2026 Cells I See #sciart contest is accepting cell images & artwork that capture the beauty of cells seen directly through the microscope or through the interpretive lens of the artist. The Grand Prize winner will receive $750. Learn more at cellsisee.ccrm.ca
CCRM tweet media
English
0
1
2
112
Signals retweetledi
CCRM
CCRM@CCRM_ca·
The fifth season of the #CCRMpodcast drops on July 15 🎉 Listen for interviews with CGT experts who share insider insights and info on timely topics. Find and follow “Commercializing Living Therapies with CCRM” to get notified, or listen at ccrm.ca/podcast
English
0
1
0
183
Signals retweetledi
Donnelly Centre
Donnelly Centre@DonnellyCentre·
The Donnelly Centre is hiring a Research and Communications Officer! This role covers the external and internal communications of our community: from news stories and social media, to web page management and event support. jobs.utoronto.ca/job/Toronto-Re…
English
0
3
4
602
Signals retweetledi
CCRM
CCRM@CCRM_ca·
CCRM has signed an MOU with Rinn Advanced Therapies to explore establishing a CCRM-affiliated hub in Ireland. CCRM Ireland would be the latest addition to CCRM’s global network, which includes @CCRM_au and CCRM Nordic. ccrm.ca/wp-content/upl…
CCRM tweet media
English
0
1
6
1.5K
Signals retweetledi
Paul Knoepfler
Paul Knoepfler@pknoepfler·
As expected, the risky new Florida stem cell law saying the FDA doesn't matter is causing all kinds of problems & boosting risks to consumers. Clinics are already cashing in. RFK isn't helping ipscell.com/2025/05/upcomi… #stemcells
English
1
2
1
188
Signals retweetledi
Dr. Jan Nolta
Dr. Jan Nolta@jan_nolta·
Congratulations Lauren, and everyone who has fought for this alongside you. 💙💜 Good luck UniQure! 🙏 #huntingtonsdisease #FDA #BLA
Lauren Holder@laurencurehd

Today feels like a victory for the entire #HuntingtonsDisease disease community. After months of uncertainty, difficult conversations, and tireless advocacy, we received the news that uniQure will be able to move forward as originally planned. For many of us, like myself, this is deeply personal. We know what it means to watch the clock in HD. We know what it means to live with the reality that time lost cannot be recovered. That's why this moment matters so much. It's also important to acknowledge that this happened because people spoke up - patients, families, caregivers, researchers, clinicians, and advocates came together and REFUSED to let our voices go unheard. We shared our stories. We signed petitions. We met with lawmakers and regulators. We educated others about what delays mean in a progressive, fatal disease where every day matters. Today is a reminder that patient voices matter. Lived experience matters. Advocacy matters. To everyone who signed, shared, spoke out, listened, supported, and stood beside this community: THANK YOU. Let's take a moment to celebrate what we accomplished together. Today, it feels like we were finally heard. #TimeMatters #StandUpSpeakUp4HD #DelayIsDamage #RareDisease @Help4HDI @FDA_KyleD @US_FDA @HDYOFeed @hdfcures @HDBuzzFeed @FDACBER @RepAuchincloss @houmanhemmati @JRenz0418 @Christina4HD @rachelreising96 @BrittanyMegan10 @POTUS @senronjohnson @flsenrickscott

English
0
2
9
542
Signals retweetledi
CCRM
CCRM@CCRM_ca·
.@CATTI was established from a partnership between CCRM and @CellCAN to tackle the workforce skills gap in biomanufacturing in Canada. With 600+ people trained so far, its mission is essential for the success of Canada’s bioeconomy. #CCRM15
CCRM tweet mediaCCRM tweet media
English
0
1
2
216
Signals retweetledi
Gladstone Institutes
Gladstone Institutes@GladstoneInst·
CAR T-cell therapy has transformed treatment for some blood cancers, but it has yet to achieve the same success against solid tumors. In the Pelka Lab at Gladstone, scientist Alisa Dietl is working to understand why.
English
0
4
5
523
Signals retweetledi
Gladstone Institutes
Gladstone Institutes@GladstoneInst·
A team led by Jennifer Doudna developed an innovative chromatin-shredding technique shown to destroy cancer cells carrying a prevalent mutation while keeping healthy cells intact. @igisci @UCSF @UCBerkeley bit.ly/4fxwoHN
English
0
3
12
996